Skip to main content
. Author manuscript; available in PMC: 2020 Aug 15.
Published in final edited form as: Clin Cancer Res. 2019 May 20;25(16):4933–4944. doi: 10.1158/1078-0432.CCR-19-0183

Table 1.

Patient demographics (n = 12)

n (%)
Female 6 (50.0%)
Age in years, mean (range) 56.0 (39 to 77)
Race
 White 6 (50.0%)
 Black 3 (25.0%)
 Other 3 (25.0%)
Ethnicity: Hispanic 1 (8.3%)
Tumor Type
 MSS Colorectal Cancer 7 (58.3%)
 Appendiceal Cancer 2 (16.7%)
 Pancreatic Cancer 1 (8.3%)
 Endometrial Cancer 1 (8.3%)
 Salivary Gland Cancer 1 (8.3%)
De novo metastatic at diagnosis 6 (50.0%)
Cancer Treatment
 Prior number of regimens, mean (range) 4.2 (1 to 8)
 Patients with Prior Immunotherapy 6 (50.0%)
 Patients on maintenance chemotherapy 1 (8.3%)

n (%) unless otherwise stated; MSS, microsatellite stable